Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients

Publisher Website
Google Scholar
Abstract
Purpose. The implications of the findings from clinical studies and pharmacokinetic analyses of the antiviral agent valganciclovir for dosing of the drug to prevent cytomegalovirus (CMV) disease in solid organ transplant recipients are reviewed.

This publication has 0 references indexed in Scilit: